Literature DB >> 31520320

Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS.

Wei Tu1, Patricia A Chen2, Noshin Koenig3, Daniela Gomez4, Esther Fujiwara4, M John Gill3, Linglong Kong5, Christopher Power6,7.   

Abstract

Neurocognitive impairment (NCI) among HIV-infected patients is heterogeneous in its reported presentations and frequencies. To determine the prevalence of NCI and its associated subtypes as well as predictive variables, we investigated patients with HIV/AIDS receiving universal health care. Recruited adult HIV-infected subjects underwent a neuropsychological (NP) test battery with established normative (sex-, age-, and education-matched) values together with assessment of their demographic and clinical variables. Three patient groups were identified including neurocognitively normal (NN, n = 246), HIV-associated neurocognitive disorders (HAND, n = 78), and neurocognitively impaired-other disorders (NCI-OD, n = 46). Univariate, multiple logistic regression and machine learning analyses were applied. Univariate analyses showed variables differed significantly between groups including birth continent, quality of life, substance use, and PHQ-9. Multiple logistic regression models revealed groups again differed significantly for substance use, PHQ-9 score, VACS index, and head injury. Random forest (RF) models disclosed that classification algorithms distinguished HAND from NN and NCI-OD from NN with area under the curve (AUC) values of 0.87 and 0.77, respectively. Relative importance plots derived from the RF model exhibited distinct variable rankings that were predictive of NCI status for both NN versus HAND and NN versus NCI-OD comparisons. Thus, NCI was frequently detected (33.5%) although HAND prevalence (21%) was lower than in several earlier reports underscoring the potential contribution of other factors to NCI. Machine learning models uncovered variables related to individual NCI types that were not identified by univariate or multiple logistic regression analyses, highlighting the value of other approaches to understanding NCI in HIV/AIDS.

Entities:  

Keywords:  Comorbidity; HIV-associated neurocognitive disorders; Machine learning; Neurocognitive impairment; Neuropsychology

Mesh:

Year:  2019        PMID: 31520320     DOI: 10.1007/s13365-019-00791-6

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  33 in total

Review 1.  Life expectancy living with HIV: recent estimates and future implications.

Authors:  Fumiyo Nakagawa; Margaret May; Andrew Phillips
Journal:  Curr Opin Infect Dis       Date:  2013-02       Impact factor: 4.915

2.  Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.

Authors:  Tanja Su; Judith Schouten; Gert J Geurtsen; Ferdinand W Wit; Ineke G Stolte; Maria Prins; Peter Portegies; Matthan W A Caan; Peter Reiss; Charles B Majoie; Ben A Schmand
Journal:  AIDS       Date:  2015-03-13       Impact factor: 4.177

3.  Neurocognitive Impairment in a Chronically Well-Suppressed HIV-Infected Population: The Dutch TREVI Cohort Study.

Authors:  Lennert W J van den Dries; Marlies N Wagener; Lize C Jiskoot; Merel Visser; Kevin R Robertson; Kirsten S Adriani; Eric C M van Gorp
Journal:  AIDS Patient Care STDS       Date:  2017-08       Impact factor: 5.078

4.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

5.  Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS.

Authors:  Sarah Tymchuk; Daniela Gomez; Noshin Koenig; M John Gill; Esther Fujiwara; Christopher Power
Journal:  Can J Psychiatry       Date:  2017-12-11       Impact factor: 4.356

6.  Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care.

Authors:  J A McCombe; P Vivithanaporn; M J Gill; C Power
Journal:  HIV Med       Date:  2012-09-20       Impact factor: 3.180

7.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Authors:  R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

Review 8.  HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Authors:  Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

9.  Mini-cog performance: novel marker of post discharge risk among patients hospitalized for heart failure.

Authors:  Apurva Patel; Roosha Parikh; Erik H Howell; Eileen Hsich; Steven H Landers; Eiran Z Gorodeski
Journal:  Circ Heart Fail       Date:  2014-12-04       Impact factor: 8.790

10.  Random forest-based similarity measures for multi-modal classification of Alzheimer's disease.

Authors:  Katherine R Gray; Paul Aljabar; Rolf A Heckemann; Alexander Hammers; Daniel Rueckert
Journal:  Neuroimage       Date:  2012-10-04       Impact factor: 6.556

View more
  6 in total

1.  Using neuronal extracellular vesicles and machine learning to predict cognitive deficits in HIV.

Authors:  Lynn Pulliam; Michael Liston; Bing Sun; Jared Narvid
Journal:  J Neurovirol       Date:  2020-07-17       Impact factor: 2.643

2.  Multi-label, multi-domain learning identifies compounding effects of HIV and cognitive impairment.

Authors:  Jiequan Zhang; Qingyu Zhao; Ehsan Adeli; Adolf Pfefferbaum; Edith V Sullivan; Robert Paul; Victor Valcour; Kilian M Pohl
Journal:  Med Image Anal       Date:  2021-10-13       Impact factor: 8.545

3.  Classifying Non-Dementia and Alzheimer's Disease/Vascular Dementia Patients Using Kinematic, Time-Based, and Visuospatial Parameters: The Digital Clock Drawing Test.

Authors:  Anis Davoudi; Catherine Dion; Shawna Amini; Patrick J Tighe; Catherine C Price; David J Libon; Parisa Rashidi
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  Super-variants identification for brain connectivity.

Authors:  Ting Li; Jianchang Hu; Shiying Wang; Heping Zhang
Journal:  Hum Brain Mapp       Date:  2020-11-24       Impact factor: 5.038

5.  Cognitive Functioning and Its Relationship with Self-Stigma in Men with HIV Who Have Sex with Men: The Mediating Role of Health-Related Quality of Life.

Authors:  Nicolás Ruiz-Robledillo; Violeta Clement-Carbonell; Rosario Ferrer-Cascales; Irene Portilla-Tamarit; Cristian Alcocer-Bruno; Eva Gabaldón-Bravo
Journal:  Psychol Res Behav Manag       Date:  2021-12-16

6.  Factors associated to neurocognitive impairment in older adults living with HIV.

Authors:  Júlia Gutierrez-San-Juan; Itziar Arrieta-Aldea; Isabel Arnau-Barrés; Greta García-Escobar; Elisabet Lerma-Chipirraz; Paula Pérez-García; Agustin Marcos; Fabiola Blasco-Hernando; Alicia Gonzalez-Mena; Esperanza Cañas; Hernando Knobel; Robert Güerri-Fernández
Journal:  Eur J Med Res       Date:  2022-02-02       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.